{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T12:29:23Z","timestamp":1789475363473,"version":"build-2803163510"},"reference-count":62,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T00:00:00Z","timestamp":1748995200000},"content-version":"vor","delay-in-days":3,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,6,2]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n               <jats:p>Hypertension is a major cause and the predominant accelerator of progressive loss of renal function in patients with chronic kidney disease (CKD). Despite advances in pharmacological intervention in recent years, a significant proportion of patients with CKD have uncontrolled, often treatment-resistant hypertension, necessitating alternative therapeutic approaches to control hypertension and slow the progression of renal function decline. Renal denervation modifies efferent and afferent renal sympathetic nerve activity and thus addresses an important modifier of both, blood pressure and renal function that has not been adequately addressed by pharmacologic therapies. This article reviews the current evidence on renal denervation in hypertensive patients with CKD. Safety and efficacy data from clinical trials and observational studies are reassuring that renal denervation is emerging as a promising additional treatment option for patients with uncontrolled hypertension and CKD. However, further randomized controlled data are needed to support these findings, particularly in patients with advanced CKD.<\/jats:p>","DOI":"10.1093\/ckj\/sfaf126","type":"journal-article","created":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T16:47:51Z","timestamp":1749055671000},"source":"Crossref","is-referenced-by-count":6,"title":["Renal denervation is effective in reducing blood pressure in patients with CKD"],"prefix":"10.1093","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6952-4660","authenticated-orcid":false,"given":"Agnes","family":"Bosch","sequence":"first","affiliation":[{"name":"Friedrich-Alexander-University Erlangen-N\u00fcrnberg (FAU) Department of Nephrology and Hypertension, , Erlangen,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dennis","family":"Kannenkeril","sequence":"additional","affiliation":[{"name":"Friedrich-Alexander-University Erlangen-N\u00fcrnberg (FAU) Department of Nephrology and Hypertension, , Erlangen,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roland E","family":"Schmieder","sequence":"additional","affiliation":[{"name":"Friedrich-Alexander-University Erlangen-N\u00fcrnberg (FAU) Department of Nephrology and Hypertension, , Erlangen,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,6,4]]},"reference":[{"key":"2025060905564300400_bib1","doi-asserted-by":"publisher","first-page":"4019","DOI":"10.1093\/eurheartj\/ehae466","article-title":"European Society of Cardiology: the 2023 Atlas of Cardiovascular Disease Statistics","volume":"45","author":"Timmis","year":"2024","journal-title":"Eur Heart J"},{"key":"2025060905564300400_bib2","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1016\/S0140-6736(21)01330-1","article-title":"Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participants","volume":"398","author":"NCD Risk Factor Collaboration (NCD-RisC)","year":"2021","journal-title":"Lancet"},{"key":"2025060905564300400_bib3","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1056\/NEJMoa2206916","article-title":"Global effect of modifiable risk factors on cardiovascular disease and mortality","volume":"389","author":"Global Cardiovascular Risk Consortium","year":"2023","journal-title":"N Engl J Med"},{"key":"2025060905564300400_bib4","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.kint.2021.09.026","article-title":"Diagnosis and treatment of arterial hypertension 2021","volume":"101","author":"Ott","year":"2022","journal-title":"Kidney Int"},{"key":"2025060905564300400_bib5","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1093\/ndt\/gfae041","article-title":"A European Renal Association (ERA) synopsis for nephrology practice of the 2023 European Society of Hypertension (ESH) Guidelines for the Management of Arterial Hypertension","volume":"39","author":"Sarafidis","year":"2024","journal-title":"Nephrol Dial Transplant"},{"key":"2025060905564300400_bib6","doi-asserted-by":"publisher","first-page":"2694","DOI":"10.1093\/ndt\/gfad118","article-title":"Hypertension in chronic kidney disease-treatment standard 2023","volume":"38","author":"Georgianos","year":"2023","journal-title":"Nephrol Dial Transplant"},{"key":"2025060905564300400_bib7","doi-asserted-by":"publisher","first-page":"R245","DOI":"10.1152\/ajpregu.00647.2009","article-title":"Translational medicine: the antihypertensive effect of renal denervation","volume":"298","author":"DiBona","year":"2010","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"2025060905564300400_bib8","doi-asserted-by":"publisher","first-page":"2976","DOI":"10.1161\/CIRCULATIONAHA.112.130880","article-title":"Renal sympathetic denervation for treatment of drug-resistant hypertension: one-year results from the Symplicity HTN-2 randomized, controlled trial","volume":"126","author":"Esler","year":"2012","journal-title":"Circulation"},{"key":"2025060905564300400_bib9","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1093\/eurheartj\/ehu441","article-title":"Predictors of blood pressure response in the SYMPLICITY HTN-3 trial","volume":"36","author":"Kandzari","year":"2015","journal-title":"Eur Heart J"},{"key":"2025060905564300400_bib10","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1056\/NEJMoa1402670","article-title":"A controlled trial of renal denervation for resistant hypertension","volume":"370","author":"Bhatt","year":"2014","journal-title":"N Engl J Med"},{"key":"2025060905564300400_bib11","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1038\/nrcardio.2014.70-c2","article-title":"Renal denervation\u2014a valid treatment option despite SYMPLICITY HTN-3","volume":"11","author":"Schmieder","year":"2014","journal-title":"Nat Rev Cardiol"},{"key":"2025060905564300400_bib12","doi-asserted-by":"publisher","first-page":"612","DOI":"10.4244\/EIJ-D-23-00264","article-title":"Histological examination of renal nerve distribution, density, and function in humans","volume":"19","author":"Struthoff","year":"2023","journal-title":"EuroIntervention"},{"key":"2025060905564300400_bib13","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1161\/HYPERTENSIONAHA.120.15106","article-title":"Microdissection of the human renal nervous system: implications for performing renal denervation procedures","volume":"76","author":"Garcia-Touchard","year":"2020","journal-title":"Hypertension"},{"key":"2025060905564300400_bib14","doi-asserted-by":"publisher","first-page":"1759","DOI":"10.1161\/HYPERTENSIONAHA.123.21283","article-title":"Outcomes following radiofrequency renal denervation according to antihypertensive medications: subgroup analysis of the global SYMPLICITY registry DEFINE","volume":"80","author":"Mahfoud","year":"2023","journal-title":"Hypertension"},{"key":"2025060905564300400_bib15","doi-asserted-by":"crossref","first-page":"e63","DOI":"10.1161\/HYPERTENSIONAHA.123.22314","article-title":"Long-term blood pressure reductions following catheter-based renal denervation: a systematic review and meta-analysis","volume":"81","author":"Sesa-Ashton","year":"2024","journal-title":"Hypertension"},{"key":"2025060905564300400_bib16","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1016\/j.jacc.2022.11.038","article-title":"10-Year outcomes of catheter-based renal denervation in patients with resistant hypertension","volume":"81","author":"Al Ghorani","year":"2023","journal-title":"J Am Coll Cardiol"},{"key":"2025060905564300400_bib17","doi-asserted-by":"publisher","first-page":"1210801","DOI":"10.3389\/fcvm.2023.1210801","article-title":"Safety and efficacy of renal sympathetic denervation: a 9-year long-term follow-up of 24-hour ambulatory blood pressure measurements","volume":"10","author":"Vogt","year":"2023","journal-title":"Front Cardiovasc Med"},{"key":"2025060905564300400_bib18","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.1161\/CIRCULATIONAHA.124.069709","article-title":"Effects of catheter-based renal denervation in hypertension: a systematic review and meta-analysis","volume":"150","author":"Vukadinovic","year":"2024","journal-title":"Circulation"},{"key":"2025060905564300400_bib19","doi-asserted-by":"publisher","first-page":"2879","DOI":"10.1016\/j.jacc.2020.04.036","article-title":"Renal denervation in high-risk patients with hypertension","volume":"75","author":"Mahfoud","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"2025060905564300400_bib20","doi-asserted-by":"publisher","first-page":"3912","DOI":"10.1093\/eurheartj\/ehae178","article-title":"2024 ESC guidelines for the management of elevated blood pressure and hypertension","volume":"45","author":"McEvoy","year":"2024","journal-title":"Eur Heart J"},{"key":"2025060905564300400_bib21","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1097\/HJH.0000000000003480","article-title":"2023 ESH Guidelines for the management of arterial hypertension The Task Force for the management of arterial hypertension of the European Society of Hypertension: endorsed by the International Society of Hypertension (ISH) and the European Renal Association (ERA)","volume":"41","author":"Mancia","year":"2023","journal-title":"J Hypertens"},{"key":"2025060905564300400_bib22","doi-asserted-by":"publisher","first-page":"R127","DOI":"10.4244\/EIJV9SRA22","article-title":"Chronic kidney disease: role of sympathetic nervous system activation and potential benefits of renal denervation","volume-title":"EuroIntervention","author":"Hering","year":"2013"},{"key":"2025060905564300400_bib23","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1161\/HYPERTENSIONAHA.113.03140","article-title":"Disproportional decrease in office blood pressure compared with 24-hour ambulatory blood pressure with antihypertensive treatment: dependency on pretreatment blood pressure levels","volume":"64","author":"Schmieder","year":"2014","journal-title":"Hypertension"},{"key":"2025060905564300400_bib24","doi-asserted-by":"publisher","first-page":"2214","DOI":"10.1016\/j.ijcard.2013.01.218","article-title":"Feasibility of catheter-based renal nerve ablation and effects on sympathetic nerve activity and blood pressure in patients with end-stage renal disease","volume":"168","author":"Schlaich","year":"2013","journal-title":"Int J Cardiol"},{"key":"2025060905564300400_bib25","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1038\/nrneph.2014.59","article-title":"Renal denervation\u2014implications for chronic kidney disease","volume":"10","author":"Veelken","year":"2014","journal-title":"Nat Rev Nephrol"},{"key":"2025060905564300400_bib26","doi-asserted-by":"publisher","first-page":"1912","DOI":"10.1056\/NEJM199212313272704","article-title":"Sympathetic overactivity in patients with chronic renal failure","volume":"327","author":"Converse","year":"1992","journal-title":"N Engl J Med"},{"key":"2025060905564300400_bib27","doi-asserted-by":"publisher","first-page":"e002426","DOI":"10.1161\/JAHA.115.002426","article-title":"Increased sympathetic renal innervation in hemodialysis patients is the anatomical substrate of sympathetic hyperactivity in end-stage renal disease","volume":"4","author":"Mauriello","year":"2015","journal-title":"J Am Heart Assoc"},{"key":"2025060905564300400_bib28","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1097\/HJH.0000000000002661","article-title":"Sympathetic nerve traffic overactivity in chronic kidney disease: a systematic review and meta-analysis","volume":"39","author":"Grassi","year":"2021","journal-title":"J Hypertens"},{"key":"2025060905564300400_bib29","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1161\/HYPERTENSIONAHA.123.21715","article-title":"Sympathetic pathophysiology in hypertension origins: the path to renal denervation","volume":"81","author":"Esler","year":"2024","journal-title":"Hypertension"},{"key":"2025060905564300400_bib30","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1016\/j.kint.2022.02.036","article-title":"KDIGO recommendations on blood pressure management in chronic kidney disease","volume":"101","author":"Subbiah","year":"2022","journal-title":"Kidney Int"},{"key":"2025060905564300400_bib31","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1038\/s41440-021-00754-7","article-title":"Catheter-based ultrasound renal denervation in patients with resistant hypertension: the randomized, controlled REQUIRE trial","volume":"45","author":"Kario","year":"2022","journal-title":"Hypertens Res"},{"key":"2025060905564300400_bib32","doi-asserted-by":"publisher","first-page":"2160","DOI":"10.1016\/S0140-6736(17)32281-X","article-title":"Catheter-based renal denervation in patients with uncontrolled hypertension in the absence of antihypertensive medications (SPYRAL HTN-OFF MED): a randomised, sham-controlled, proof-of-concept trial","volume":"390","author":"Townsend","year":"2017","journal-title":"Lancet"},{"key":"2025060905564300400_bib33","doi-asserted-by":"publisher","first-page":"2346","DOI":"10.1016\/S0140-6736(18)30951-6","article-title":"Effect of renal denervation on blood pressure in the presence of antihypertensive drugs: 6-month efficacy and safety results from the SPYRAL HTN-ON MED proof-of-concept randomised trial","volume":"391","author":"Kandzari","year":"2018","journal-title":"Lancet"},{"key":"2025060905564300400_bib34","doi-asserted-by":"publisher","first-page":"2335","DOI":"10.1016\/S0140-6736(18)31082-1","article-title":"Endovascular ultrasound renal denervation to treat hypertension (RADIANCE-HTN SOLO): a multicentre, international, single-blind, randomised, sham-controlled trial","volume":"391","author":"Azizi","year":"2018","journal-title":"Lancet"},{"key":"2025060905564300400_bib35","doi-asserted-by":"publisher","first-page":"2476","DOI":"10.1016\/S0140-6736(21)00788-1","article-title":"Ultrasound renal denervation for hypertension resistant to a triple medication pill (RADIANCE-HTN TRIO): a randomised, multicentre, single-blind, sham-controlled trial","volume":"397","author":"Azizi","year":"2021","journal-title":"Lancet"},{"key":"2025060905564300400_bib36","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1016\/S0140-6736(20)30554-7","article-title":"Efficacy of catheter-based renal denervation in the absence of antihypertensive medications (SPYRAL HTN-OFF MED Pivotal): a multicentre, randomised, sham-controlled trial","volume":"395","author":"Bohm","year":"2020","journal-title":"Lancet"},{"key":"2025060905564300400_bib37","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/j.jcin.2019.10.061","article-title":"The REDUCE HTN: REINFORCE: randomized, sham-controlled trial of bipolar radiofrequency renal denervation for the treatment of hypertension","volume":"13","author":"Weber","year":"2020","journal-title":"JACC Cardiovasc Interv"},{"key":"2025060905564300400_bib38","doi-asserted-by":"publisher","first-page":"3474","DOI":"10.1093\/eurheartj\/ehz118","article-title":"Effects of renal denervation on kidney function and long-term outcomes: 3-year follow-up from the Global SYMPLICITY Registry","volume":"40","author":"Mahfoud","year":"2019","journal-title":"Eur Heart J"},{"key":"2025060905564300400_bib39","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1080\/02656736.2021.1916100","article-title":"Efficacy and safety of renal denervation for hypertension in patients with chronic kidney disease: a meta-analysis","volume":"38","author":"Xia","year":"2021","journal-title":"Int J Hyperthermia"},{"key":"2025060905564300400_bib40","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1111\/j.1523-1755.2005.00406.x","article-title":"Atherosclerotic renovascular disease in United States patients aged 67 years or older: risk factors, revascularization, and prognosis","volume":"68","author":"Kalra","year":"2005","journal-title":"Kidney Int"},{"key":"2025060905564300400_bib41","doi-asserted-by":"publisher","first-page":"89","DOI":"10.4244\/EIJ-D-19-00902","article-title":"Review and meta-analysis of renal artery damage following percutaneous renal denervation with radiofrequency renal artery ablation","volume":"16","author":"Townsend","year":"2020","journal-title":"EuroIntervention"},{"key":"2025060905564300400_bib42","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2024.09.560","article-title":"Renal artery imaging through 36-months following radiofrequency renal denervation: results from the SPYRAL Clinical Program","author":"Mahfoud","year":"2024","journal-title":"Abstract Transcatheter Cardiovascular Therapeutics Conference (TCT) 2024:"},{"key":"2025060905564300400_bib43","doi-asserted-by":"publisher","first-page":"71","DOI":"10.2147\/IBPC.S248579","article-title":"Renal artery stenosis in the patient with hypertension: prevalence, impact and management","volume":"13","author":"Manaktala","year":"2020","journal-title":"Integr Blood Press Control"},{"key":"2025060905564300400_bib44","doi-asserted-by":"publisher","first-page":"e467","DOI":"10.4244\/EIJ-D-23-00836","article-title":"Renal denervation in the management of hypertension","volume":"20","author":"Lauder","year":"2024","journal-title":"EuroIntervention"},{"key":"2025060905564300400_bib45","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1093\/ndt\/gfab154","article-title":"Renal denervation in patients with versus without chronic kidney disease: results from the Global SYMPLICITY Registry with follow-up data of 3 years","volume":"37","author":"Ott","year":"2022","journal-title":"Nephrol Dial Transplant"},{"key":"2025060905564300400_bib46","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1007\/s40620-021-00966-7","article-title":"Insights on safety and efficacy of renal artery denervation for uncontrolled-resistant hypertension in a high risk population with chronic kidney disease: first Italian real-world experience","volume":"34","author":"Marin","year":"2021","journal-title":"J Nephrol"},{"key":"2025060905564300400_bib47","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1111\/jch.12724","article-title":"Long-term effects of renal sympathetic denervation on hypertensive patients with mild to moderate chronic kidney disease","volume":"18","author":"Kiuchi","year":"2016","journal-title":"J Clin Hypertens (Greenwich)"},{"key":"2025060905564300400_bib48","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1016\/j.jacc.2011.05.023","article-title":"Renal function-based contrast dosing to define safe limits of radiographic contrast media in patients undergoing percutaneous coronary interventions","volume":"58","author":"Gurm","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"2025060905564300400_bib49","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1093\/eurheartj\/ehad054","article-title":"Renal denervation in the management of hypertension in adults. A clinical consensus statement of the ESC Council on Hypertension and the European Association of Percutaneous Cardiovascular Interventions (EAPCI)","volume":"44","author":"Barbato","year":"2023","journal-title":"Eur Heart J"},{"key":"2025060905564300400_bib50","doi-asserted-by":"publisher","first-page":"sfad237","DOI":"10.1093\/ckj\/sfad237","article-title":"Blood pressure reduction after renal denervation in patients with or without chronic kidney disease","volume":"17","author":"Gunes-Altan","year":"2024","journal-title":"Clin Kidney J"},{"key":"2025060905564300400_bib51","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2024fzrm66ak","article-title":"Radiofrequency renal denervation in patients with severe CKD, including patients on dialysis: analysis from the Global SYMPLICITY Registry DEFINE","volume":"35","author":"Schlaich","year":"2024","journal-title":"J Am Soc Nephrol"},{"key":"2025060905564300400_bib52","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2024shmc814q","article-title":"Effect of ultrasound renal denervation in patients with CKD: a matched-controlled analysis of the RADIANCE Clinical trial Program: TH-PO1066","volume":"35","author":"Schmieder","year":"2024","journal-title":"J Am Soc Nephrol"},{"key":"2025060905564300400_bib53","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1097\/HJH.0000000000000556","article-title":"Renal denervation preserves renal function in patients with chronic kidney disease and resistant hypertension","volume":"33","author":"Ott","year":"2015","journal-title":"J Hypertens"},{"key":"2025060905564300400_bib54","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1681\/ASN.2011111062","article-title":"Renal denervation in moderate to severe CKD","volume":"23","author":"Hering","year":"2012","journal-title":"J Am Soc Nephrol"},{"key":"2025060905564300400_bib55","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.ijcard.2017.01.047","article-title":"Effect of renal denervation on kidney function in patients with chronic kidney disease","volume":"232","author":"Hering","year":"2017","journal-title":"Int J Cardiol"},{"key":"2025060905564300400_bib56","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.1161\/HYPERTENSIONAHA.124.22819","article-title":"Impact of renal denervation on urinary peptide-based biomarkers in hypertension","volume":"81","author":"Lauder","year":"2024","journal-title":"Hypertension"},{"key":"2025060905564300400_bib57","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1007\/s40292-023-00621-1","article-title":"Renal denervation in end-stage renal disease: current evidence and perspectives","volume-title":"High Blood Press Cardiovasc Prev","author":"Scalise","year":"2024"},{"key":"2025060905564300400_bib58","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1111\/jch.12017","article-title":"Renal denervation in a hypertensive patient with end-stage renal disease and small arteries: a direction for future research","volume":"14","author":"Ott","year":"2012","journal-title":"J Clin Hypertens (Greenwich)"},{"key":"2025060905564300400_bib59","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1007\/s10157-019-01697-7","article-title":"Effects of renal denervation on blood pressure in hypertensive patients with end-stage renal disease: a single centre experience","volume":"23","author":"Ott","year":"2019","journal-title":"Clin Exp Nephrol"},{"key":"2025060905564300400_bib60","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1097\/HJH.0000000000002358","article-title":"Renal denervation in patients with end-stage renal disease and resistant hypertension on long-term haemodialysis","volume":"38","author":"Scalise","year":"2020","journal-title":"J Hypertens"},{"key":"2025060905564300400_bib61","doi-asserted-by":"publisher","first-page":"1928","DOI":"10.1093\/ndt\/gfv311","article-title":"Impact of sympathetic renal denervation: a randomized study in patients after renal transplantation (ISAR-denerve)","volume":"30","author":"Schneider","year":"2015","journal-title":"Nephrol Dial Transplant"},{"key":"2025060905564300400_bib62","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1161\/HYPERTENSIONAHA.116.07464","article-title":"Evaluation of adherence should become an integral part of assessment of patients with apparently treatment-resistant hypertension","volume":"68","author":"Berra","year":"2016","journal-title":"Hypertension"}],"container-title":["Clinical Kidney Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ckj\/advance-article-pdf\/doi\/10.1093\/ckj\/sfaf126\/63436470\/sfaf126.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ckj\/article-pdf\/18\/6\/sfaf126\/63436470\/sfaf126.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ckj\/article-pdf\/18\/6\/sfaf126\/63436470\/sfaf126.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,9]],"date-time":"2025-06-09T09:56:51Z","timestamp":1749463011000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ckj\/article\/doi\/10.1093\/ckj\/sfaf126\/8156803"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":62,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,6,2]]}},"URL":"https:\/\/doi.org\/10.1093\/ckj\/sfaf126","relation":{},"ISSN":["2048-8505","2048-8513"],"issn-type":[{"value":"2048-8505","type":"print"},{"value":"2048-8513","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,6]]},"published":{"date-parts":[[2025,6]]},"article-number":"sfaf126"}}